Recent Updates
Recently added Catalysts
CORT Positive Sentiment

Prevalence of Hypercortisolism in Individuals With Resistant Hypertension and Cardiovascular Disease

Saturday, August 1, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The presentation titled 'Prevalence of Hypercortisolism in Individuals With Resistant Hypertension and Cardiovascular Disease' was delivered by Dr. Pam R. Taub at the American Society for Preventive Cardiology Congress on July 31, 2026. This research highlights the prevalence of hypercortisolism in patients facing resistant hypertension and cardiovascular issues, suggesting important clinical implications.

Market Sentiment Analysis

POSITIVE FACTORS

  • Presentation at a notable congress indicates recognition of the research.
  • Focus on a significant health issue like resistant hypertension.
  • Potential implications for cardiovascular disease management.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+186%
120-day peak, hindsight
Typical move
6.9%
average across 3 past catalysts
Cash runway
~58 mo
Minimal dilution risk
Lead asset
mifepristone + fluvastatin
Phase 1 · Healthy Subjects

Full Press Release Details

Presented : American Society for Preventive Cardiology ( ASPC ) 2026 Congress on CVD Prevention, 31 July 2026, Scottsdale , AZ
Presenter : Pam R. Taub , MD
Scientific journal publications or scientific congress presentations may include information regarding investigational products or uses.
Download Poster
The post Prevalence of Hypercortisolism in Individuals With Resistant Hypertension and Cardiovascular Disease appeared first on Corcept Therapeutics .

Frequently Asked Questions

What was the focus of the presentation?

The presentation focused on the prevalence of hypercortisolism in individuals with resistant hypertension and cardiovascular disease.

Who presented the research at the congress?

Dr. Pam R. Taub presented the research at the American Society for Preventive Cardiology Congress.

When was the presentation delivered?

The presentation was delivered on July 31, 2026.

Where did the ASPC Congress take place?

The ASPC Congress took place in Scottsdale, AZ.

ShareAdd on Google
Tags: CORT Viatris Investor Conferences Healthcare hypertension cardiovascular disease ASPC 2026 Pam R. Taub
Last updated: Aug 1, 2026

Biotech snapshot

Cash runway
$338M liquidity · $6M/mo burn
~58 mo
Minimal dilution risk
Lead asset
mifepristone + fluvastatinPhase 1
Healthy Subjects →

Catalyst track record

+186%
best trade around CORT's most recent catalyst

Peak hindsight return over a 120-day window, across 3 tracked FDA/PDUFA catalysts for CORT.

See every catalyst's timing & PoA →